Other grades of this product :
| GSK2636771 Basic information |
| Product Name: | GSK2636771 | | Synonyms: | GSK2636771;2-Methyl-1-[[2-Methyl-3-(trifluoroMethyl)phenyl]Methyl]-6-(4-Morpholinyl)-1H-benziMidazole-4-carboxylic acid;GSK2636771/GSK-2636771;GSK 2636771 dihydrochloride;2-Methyl-1-(2-methyl-3-(trifluoromethyl)benzyl)-6-morpholino-1H-benzo[d]imidazole-4-carboxylic;1H-Benzimidazole-4-carboxylic acid, 2-methyl-1-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-(4-morpholinyl)-;2-Methyl-1-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-(4-morpholinyl)-1H-benzimidazole-4-carboxylic acid GSK2636771;2-METHYL-1-[[2-METHYL-3-(TRIFLUOROMETHYL)PHENYL]METHYL]-6-MORPHOLIN-4-YLBENZIMIDAZOLE-4-CARBOXYLIC ACID | | CAS: | 1372540-25-4 | | MF: | C22H22F3N3O3 | | MW: | 433.42 | | EINECS: | | Product Categories: | Inhibitors;PI3K/Akt/mTOR;Akt;mTOR;PI3K;api | | Mol File: | 1372540-25-4.mol |
| GSK2636771 Chemical Properties |
| Melting point | >225°C (dec.) | | Boiling point | 641.3±55.0 °C(Predicted) | | density | 1.38 | | storage temp. | -20°C Freezer | | solubility | DMSO (Slightly), Methanol (Slightly) | | pka | -2.70±0.30(Predicted) | | form | Solid | | color | Pale Yellow |
| GSK2636771 Usage And Synthesis |
| Uses | GSK2636771 is a potent, orally bioavailable, PI3Kβ-selective inhibitor, sensitive to PTEN null cell lines. |
| GSK2636771 Preparation Products And Raw materials |
|
日本语
한국어
Français
Deutsch
España
Türkiye